Medical University of South Carolina

Medical-University-of-South-Carolina

BERG and the Medical University of South Carolina have formed a strategic partnership, designed to identify new therapeutic pathways and potential biomarkers to treat Lupus. BERG’s Interrogative Biology® platform will be applied to several serum, urine, and kidney data points from select individuals, both lupus patients and controls followed in the Medical University of South Carolina rheumatology clinics.